Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat.

D Poynter, C R Pick, R A Harcourt, S A Selway, G Ainge, I W Harman, N W Spurling, P A Fluck, J L Cook

The oral administration of loxtidine, a potent histamine H2-antagonist, to a total of 378 rats at doses of 50, 185, or 685 mg/kg/day for 116 weeks resulted in the late formation of carcinoid tumours of the gastric fundus. The first such tumour was detected after 712 days of treatment. There was no dose related response; 11 rats at the low level of treatment were affected, 12 at the intermediate and 11 at the high. Twenty seven females but only seven males were affected. No gastric tumours were found in the 228 controls. There is no evidence that loxtidine acts as a direct carcinogen and it is suggested that the tumours were the result of prolonged achlorhydria produced by a potent unsurmountable histamine H2 receptor antagonist.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Kuwamura, M., Okajima, R., Yamate, J., Kotani, T., Kuramoto, T., Serikawa, T. (2008). Pancreatic Metaplasia in the Gastro-achlorhydria in WTC-dfk Rat, a Potassium Channel Kcnq1 Mutant. Vet Pathol 45: 586-591 [Abstract] [Full Text]  
• Martinsen, T. C., Bakke, I., Chen, D., Sandvik, A. K., Zahlsen, K., Aamo, T., Waldum, H. L. (2005). Ciprofibrate stimulates the gastrin-producing cell by acting luminally on antral PPAR-{alpha}. Am. J. Physiol. Gastrointest. Liver Physiol. 289: G1052-G1060 [Abstract] [Full Text]  
• Fossmark, R., Martinsen, T. C., Bakkelund, K. E., Kawase, S., Waldum, H. L. (2004). ECL-Cell Derived Gastric Cancer in Male Cotton Rats Dosed with the H2-Blocker Loxtidine. Cancer Res. 64: 3687-3693 [Abstract] [Full Text]  
• Martinsen, T. C., Kawase, S., Hakanson, R., Torp, S. H., Fossmark, R., Qvigstad, G., Sandvik, A. K., Waldum, H. L. (2003). Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist. Carcinogenesis 24: 1887-1896 [Abstract] [Full Text]  
• Hagiwara, A., Takesada, Y., Tanaka, H., Tamano, S., Hirose, M., Ito, N., Shirai, T. (2001). Dose-dependent Induction of Glandular Stomach Preneoplastic and Neoplastic Lesions in Male F344 Rats Treated with Catechol Chronically. Toxicol Pathol 29: 180-186 [Abstract]  
• Romero, A., Gomez, F., Villamayor, F., Sacristan, A., Ortiz, J.-A. (1996). Study of the Population of Enterochromaffin-Like Cells in Mouse Gastric Mucosa after Long-Term Treatment with Ebrotidine. Toxicol Pathol 24: 160-165 [Abstract]  
• MacDonald, J. S., Lankas, G. R., Morrissey, R. E. (1994). Toxicokinetic and Mechanistic Considerations in the Interpretation of the Rodent Bioassay. Toxicol Pathol 22: 124-140 [Abstract]  
• Hixson, L. J, Kelley, C. L., Jones, W. N., Tuohy, C. D. (1992). Current Trends in the Pharmacotherapy for Gastroesophageal Reflux Disease. Arch Intern Med 152: 717-723 [Abstract]  
• Spurling, N.W., Selway, S.A.M., Poynter, D. (1989). An Evaluation of the Safety of Ranitidine During Seven Years Daily Oral Administration to Beagle Dogs. Hum Exp Toxicol 8: 23-32 [Abstract]  
• Hirth, R. S., Evans, L. D., Buroker, R. A., Oleson, F. B. (1988). Gastric Enterochromaffin-Like Cell Hyperplasia and Neoplasia in the Rat: An Indirect Effect of the Histamine H2-Receptor Antagonist, BL-6341. Toxicol Pathol 16: 273-287 [Abstract]  
• Betton, G. R., Dormer, C. S., Wells, T., Pert, P., Price, C. A., Buckley, P. (1988). Gastric ECL-Cell Hyperplasia and Carcinoids in Rodents Following Chronic Administration of H2-Antagonists SK&F 93479 and Oxmetidine and Omeprazole. Toxicol Pathol 16: 288-298 [Abstract]  
• Streett, C. S., Robertson, J. L., Crissman, J. W. (1988). Morphologic Stomach Findings in Rats and Mice Treated with the H2 Receptor Antagonists, ICI 125,211 and ICI 162,846. Toxicol Pathol 16: 299-304 [Abstract]